Metz Matthew, Shlaes David M
U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Broad Spectrum Antimicrobials Program, Washington, DC, USA
Anti-Infectives Consulting LLC, Stonington, Connecticut, USA.
Antimicrob Agents Chemother. 2014 Aug;58(8):4253-6. doi: 10.1128/AAC.02623-14. Epub 2014 May 27.
The fight against antibiotic resistance must be strengthened. We propose actions that U.S. government agencies and private sector entities can take to build a more comprehensive effort. These actions can increase the viability of investing in new antibiotics, ensure the quality and stewardship of all antibiotics, and make responses to emerging resistance more informed. Success requires the thoughtful exercise of federal authority and a firm commitment to share data and reward developers for the value generated with new, life-saving antibiotics.
必须加强对抗生素耐药性的斗争。我们提出了美国政府机构和私营部门实体可以采取的行动,以开展更全面的努力。这些行动可以提高投资开发新抗生素的可行性,确保所有抗生素的质量并合理使用,以及使对新出现的耐药性的应对更具依据。成功需要审慎运用联邦权力,并坚定承诺共享数据,以及奖励那些用新的、挽救生命的抗生素创造价值的开发者。